Feed BLTE
BL

Belite Bio, Inc

BLTE · NASDAQ

$173.40 +0.23% (+$0.40)
1M +9.15%
Market Cap $6.83B
P/E Ratio -
Div. Yield -
ROE 20.57%

Bulios Fair Price

$150.44

13.2% downside

Trenutna cena

$173.4

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica BLTE trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Odkleni pošteno ceno

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
2/9
Valuation
0 /100
Expensive
P/B 8.58x
PEG N/A
P/E N/A
Growth
100 /100
Growing
Book val. growth 164.79%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A
Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor
ROA 12.62%
ROIC 14.92%
Asset turnover 0.00x
Debt
100 /100
Low
Current ratio 33.71x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
33 /100
Unstable
Profitable years 0
Beta -1.24x
EPS volatility 53.90%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o BLTE
Online

O podjetju

Belite Bio is a biotechnology company based in the USA, specializing in the development and production of biological therapeutics for the treatment of various diseases. The company focuses on researching innovative therapies in the fields of oncology, immunology, and other areas of medicine.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

Yu-Hsin Lin

Employees

41

Headquarters

San Diego

Prihajajoči dogodki

09 NOV.

Earnings

Upcoming earnings report

48d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.